Cipla to give nebulisers to primary health care centres in India
New Delhi: Homegrown pharma major Cipla Ltd on Friday said it will donate 5,000 nebulisers to primary health care centres in India as part of its initiative to improve access to nebulisation therapy specifically for patients in rural parts of the country. These nebulisers will be distributed at CHCs (community health centres) and PHCs (primary health centres) across several states.
Maharashtra, Uttar Pradesh, Rajasthan, West Bengal, Andhra Pradesh, Telangana, Tamil Nadu, Uttarakhand, Punjab, Sikkim will be adopted by Cipla to create good nebulisation centres, spread awareness regarding the therapy and undertake training for the associated paramedical staff on the science of safe nebulisation practices, the company said in a statement.
Cipla India Business CEO Achin Gupta said, "In line with our purpose of 'Caring for Life', we aim to address the low awareness and gaps in nebulisation therapy for acute asthma across rural areas".
The adoption of these centres under the aegis of Cipla across the states within the country will help it reach far and wide to address the challenge of access to nebulisation therapy in India, he added.
"Our aim is to help as many patients as we can with respiratory disorders visiting these primary health setups for management of their acute episodes and to benefit from this cause enormously," Gupta noted.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.